XML 36 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Information
 9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Segment Information Segment Information
Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Three Months Ended September 30, 2023
Net sales1,528 1,220 — (25)(1)2,723 
Other (charges) gains, net (Note 18)
(15)— (2)— (17)
Operating profit (loss)691 (2)272 (121)— 842 
Equity in net earnings (loss) of affiliates
8 1 3 — 12 
Depreciation and amortization111 55 7 — 173 
Capital expenditures51 44 24 — 119 (3)
Three Months Ended September 30, 2022
Net sales
929 1,397 — (25)(1)2,301 
Other (charges) gains, net (Note 18)
(14)— (1)— (15)
Operating profit (loss)
114 312 (118)— 308 
Equity in net earnings (loss) of affiliates
69 1 3 — 73 
Depreciation and amortization
43 53 4 — 100 
Capital expenditures
34 74 15 — 123 (3)
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a $508 million gain related to the formation of the Nutrinova joint venture included in Gain (loss) on disposition of businesses and assets, net in the unaudited interim consolidated statements of operations (Note 3).
(3)Includes a decrease in accrued capital expenditures of $12 million and $16 million for the three months ended September 30, 2023 and 2022, respectively.
Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Nine Months Ended September 30, 2023
Net sales4,743 3,703 — (75)(1)8,371 
Other (charges) gains, net (Note 18)
(44)(1)(5)— (50)
Operating profit (loss)961 (2)845 (378)— 1,428 
Equity in net earnings (loss) of affiliates
37 4 9 — 50 
Depreciation and amortization335 163 19 — 517 
Capital expenditures154 162 63 — 379 (3)
As of September 30, 2023
Goodwill and intangible assets, net
10,518 417 — — 10,935 
Total assets
17,478 5,528 2,532 — 25,538 
Nine Months Ended September 30, 2022
Net sales
2,787 

4,608 

— (70)(1)7,325 
Other (charges) gains, net (Note 18)
(14)— (1)— (15)
Operating profit (loss)
404 1,243 (325)— 1,322 
Equity in net earnings (loss) of affiliates
171 8 10 — 189 
Depreciation and amortization
134 161 14 — 309 
Capital expenditures
99 231 39 — 369 (3)
As of December 31, 2022
Goodwill and intangible assets, net
10,826 421 — — 11,247 
Total assets
20,611 5,471 190 — 26,272 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a $508 million gain related to the formation of the Nutrinova joint venture included in Gain (loss) on disposition of businesses and assets, net in the unaudited interim consolidated statements of operations (Note 3).
(3)Includes a decrease in accrued capital expenditures of $61 million and $31 million for the nine months ended September 30, 2023 and 2022, respectively.